Vnitřní lékařství 5/2020

ORIGINAL ARTICLE Confocal laser endomicroscopy in the diagnostics of esophageal diseases: a pilot study E32 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék 2020; 66(2): e26–e32  /  www.casopisvnitrnilekarstvi.cz 5. Rastogi A, Puli S, El‑Serag HB et al. Incidence of esophageal adenocarcinoma in pati‑ ents with Barrett’s esophagus and high‑grade dysplasia: a meta‑analysis. Gastrointest En‑ dosc 2008; 67: 394–398. 6. Naini BV, Souza RF, Odze RD Barrett’s Esophagus: A Comprehensive and Contempora‑ ry Review for Pathologists. Am J Surg Pathol 2016; 40: e45–e66. 7. Wallace M, Lauwers GY, Chen Y et al. Miami classification for probe‑based confocal la‑ ser endomicroscopy. Endoscopy 2011; 43: 882–891. 8. Gaddam S, Mathur SC, Singh M et al. Novel probe‑based confocal laser endomicrosco‑ py criteria and interobserver agreement for the detection of dysplasia in Barrett’s esopha‑ gus. Am J Gastroenterol 2011; 106: 1961–1969. 9. di Pietro M, Bertani H, O'Donovan M et al. Development and Validation of Confocal En‑ domicroscopy Diagnostic Criteria for Low‑Grade Dysplasia in Barrett’s Esophagus. Clin Transl Gastroenterol 2019; 10: e00014. 10. Moravčík P, Hlavsa J, Kunovský L et al. Confocal Laser Endomicroscopy in the Diagnos‑ tics of Malignancy of the Gastrointestinal Tract. Klin Onkol 2017; 30: 258–263. 11. Fuks D, Pierangelo A, Validire P et al. Intraoperative confocal laser endomicroscopy for real‑time in vivo tissue characterization during surgical procedures. Surg Endosc 2019; 33: 1544–1552. 12. Sharma P, Meining AR, Coron E et al. Real‑time increased detection of neoplastic tis‑ sue in Barrett’s esophagus with probe‑based confocal laser endomicroscopy: final resul‑ ts of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74: 465–472. 13. Canto MI, Anandasabapathy S, Brugge W et al. In vivo endomicroscopy improves de‑ tection of Barrett’s esophagus‑related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc 2014; 79: 211–221. 14. Shah T, Lippman R, Kohli D et al. Accuracy of probe‑based confocal laser endomicrosco‑ py (pCLE) compared to random biopsies during endoscopic surveillance of Barrett’s eso‑ phagus. Endosc Int Open 2018; 6: E414–E420. 15. Kariv R, Plesec TP, Goldblum JR et al. The Seattle protocol does not more reliably pre‑ dict the detection of cancer at the time of esophagectomy than a less intensive surveillan‑ ce protocol. Clin Gastroenterol Hepatol 2009; 7: 653–658. 16. Caillol F, Godat S, Poizat F et al. Probe confocal laser endomicroscopy in the the‑ rapeutic endoscopic management of Barrett’s dysplasia. Ann Gastroenterol 2017; 30: 295–301. 17. Siegel R, NaishadhamD, Jemal A Cancer statistics, 2012 CA Cancer J Clin 2012; 62: 10–29. 18. Hur C, Miller M, Kong CY et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013; 119: 1149–1158. 19. Falk GW Barrett’s Esophagus: Frequency and Prediction of Dysplasia and Cancer. Best Pract Res Clin Gastroenterol 2015; 29: 125–138. 20. Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastro‑ enterol 2015; 21: 7933–7943. 21. Svoboda P, Dítě P, Klvaňa P et al. Risk factors and progression predictors of Barrett’s oe‑ sophagus to adenocarcinoma. Vnitř Lék 2014; 60: 467–473. 22. Pech O, Gossner L, Manner H et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy 2007; 39: 588–593. 23. Kariyawasam VC, Bourke MJ, Hourigan LF et al. Circumferential location predicts the risk of high‑grade dysplasia and early adenocarcinoma in short‑segment Barrett’s eso‑ phagus. Gastrointest Endosc 2012; 75: 938–944. 24. Pohl H, Wrobel K, Bojarski C et al. Risk factors in the development of esophageal ade‑ nocarcinoma. Am J Gastroenterol 2013; 108: 200–207. 25. Anaparthy R, Gaddam S, Kanakadandi V et al. Association between length of Ba‑ rrett’s esophagus and risk of high‑grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol 2013; 11: 1430–1436. 26. Richardson C, Colavita P, Dunst C et al. Real‑time diagnosis of Barrett’s esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with con‑ ventional histology for the identification of intestinal metaplasia in new users. Surg En‑ dosc 2019; 33: 1585–1591. 27. Fitzgerald RC, di Pietro M, Ragunath K et al. British Society of Gastroenterology gui‑ delines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7–42. 28. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esopha‑ gus with dysplasia. N Engl J Med 2009; 360: 2277–2288. 29. Kroupa R, Konečný Š, Dolina J Current trends in the diagnosis and treatment of gast‑ roesophageal reflux disease. Vnitř Lék 2018; 64: 588–594. 30. Martínek J, Falt P, Gregar J et al. Guidelines of the Czech gastroenterological society -endoscopic treatment of Barrett’s esophagus and early esophageal neoplasia. Gastro‑ ent Hepatol 2013; 67: 479–487. 31. Leers JM, DeMeester SR, Oezcelik A et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011; 253: 271–278. 32. Pimentel‑Nunes P, Dinis‑RibeiroM, Ponchon T et al. Endoscopic submucosal dissection: Eu‑ ropean Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829–854. 33. Lin JL T1 esophageal cancer, request an endoscopic mucosal resection (EMR) for in­ ‑depth review. J Thorac Dis 2013; 5: 353–356. 34. Barbour AP, Jones M, Brown I et al. Risk stratification for early esophageal adenocar‑ cinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010; 17: 2494–2502. 35. Xiong YQ, Ma SJ, Zhou JH et al. A meta‑analysis of confocal laser endomicroscopy for the detection of neoplasia in patients with Barrett’s esophagus. J Gastroenterol Hepa‑ tol 2016; 31: 1102–1110. 36. Xiong YQ, Ma SJ, Hu HY et al. Comparison of narrow‑band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett’s esophagus: A meta‑analysis. Clin Res Hepatol Gastroenterol 2018; 42: 31–39. 37. Wallace MB, Meining A, Canto MI et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010; 31: 548–552. 38. Groof J de, van der Sommen F, van der Putten J et al. The Argos project: The develop‑ ment of a computer‑aided detection system to improve detection of Barrett’s neoplasia on white light endoscopy. United Eur Gastroenterol J 2019; 7: 538–547.